OpenURL Connection Search

Select item for more details and to access through your institution.

MET dysregulation is a hallmark of aggressive disease in multiple myeloma patients.
Published in:
British Journal of Haematology, 2014, v. 164, n. 6, p. 841, doi. 10.1111/bjh.12719
By:
- Rocci, Alberto;
- Gambella, Manuela;
- Aschero, Simona;
- Baldi, Ileana;
- Trusolino, Livio;
- Cavallo, Federica;
- Gay, Francesca;
- Larocca, Alessandra;
- Magarotto, Valeria;
- Omedè, Paola;
- Isaia, Gianluca;
- Bertotti, Andrea;
- Liberati, Anna M.;
- Catalano, Lucio;
- De Rosa, Luca;
- Musto, Pellegrino;
- Vallone, Roberto;
- Falcone, Antonietta;
- Drandi, Daniela;
- Ladetto, Marco
Publication type:
Article
Clinical and Biological Early Relapse Predictors in Multiple Myeloma: An Analysis from the MMRF CoMMpass Study.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e13, doi. 10.1016/j.clml.2019.09.019
By:
- D'Agostino, Mattia;
- Zaccaria, Gian Maria;
- Ziccheddu, Bachisio;
- Genuardi, Elisa;
- Maura, Francesco;
- Oliva, Stefania;
- Auclair, Daniel;
- Yesil, Jennifer;
- Capra, Andrea;
- Colucci, Paola;
- Poggiu, Marco;
- Keats, Jonathan;
- Larocca, Alessandra;
- Gambella, Manuela;
- Bolli, Niccolo;
- Boccadoro, Mario;
- Gay, Francesca
Publication type:
Article
Prognostic Implication of Somatic Mutations by Next Generation Sequencing: an Analysis from the MMRF CoMMpass Study in Newly Diagnosed Multiple Myeloma Patients.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e94, doi. 10.1016/j.clml.2017.03.168
By:
- D'Agostino, Mattia;
- Oliva, Stefania;
- Spada, Stefano;
- Gambella, Manuela;
- DeRome, Mary;
- Cavo, Michele;
- Aglietta, Massimo;
- Offidani, Massimo;
- Yesil, Jennifer;
- Oddolo, Daniela;
- Cerrato, Chiara;
- Rossi, Giuseppe;
- Ledda, Antonio;
- Canepa, Letizia;
- Grasso, Mariella;
- Roberto, Foà;
- Auclair, Daniel;
- Musto, Pellegrino;
- Evangelista, Andrea;
- Gay, Francesca
Publication type:
Article
Indoleamine 2,3-dioxygenase 1 (IDO1) activity correlates with immune system abnormalities in multiple myeloma.
Published in:
Journal of Translational Medicine, 2012, v. 10, n. 1, p. 247, doi. 10.1186/1479-5876-10-247
By:
- Bonanno, Giuseppina;
- Mariotti, Andrea;
- Procoli, Annabella;
- Folgiero, Valentina;
- Natale, Daniela;
- De Rosa, Luca;
- Majolino, Ignazio;
- Novarese, Linda;
- Rocci, Alberto;
- Gambella, Manuela;
- Ciciarello, Marilena;
- Scambia, Giovanni;
- Palumbo, Antonio;
- Locatelli, Franco;
- De Cristofaro, Raimondo;
- Rutella, Sergio
Publication type:
Article
Indoleamine 2,3-dioxygenase 1 (IDO1) activity correlates with immune system abnormalities in multiple myeloma.
Published in:
2012
By:
- Bonanno, Giuseppina;
- Mariotti, Andrea;
- Procoli, Annabella;
- Folgiero, Valentina;
- Natale, Daniela;
- De Rosa, Luca;
- Majolino, Ignazio;
- Novarese, Linda;
- Rocci, Alberto;
- Gambella, Manuela;
- Ciciarello, Marilena;
- Scambia, Giovanni;
- Palumbo, Antonio;
- Locatelli, Franco;
- De Cristofaro, Raimondo;
- Rutella, Sergio
Publication type:
journal article
Minimal residual disease by flow cytometry and allelic-specific oligonucleotide real-time quantitative polymerase chain reaction in patients with myeloma receiving lenalidomide maintenance: A pooled analysis.
Published in:
2019
By:
- Gambella, Manuela;
- Omedé, Paola;
- Spada, Stefano;
- Muccio, Vittorio Emanuele;
- Gilestro, Milena;
- Saraci, Elona;
- Grammatico, Sara;
- Larocca, Alessandra;
- Conticello, Concetta;
- Bernardini, Annalisa;
- Gamberi, Barbara;
- Troia, Rossella;
- Liberati, Anna Marina;
- Offidani, Massimo;
- Rocci, Alberto;
- Palumbo, Antonio;
- Cavo, Michele;
- Sonneveld, Pieter;
- Boccadoro, Mario;
- Oliva, Stefania
Publication type:
journal article

Found: 6

MET dysregulation is a hallmark of aggressive disease in multiple myeloma patients.

Clinical and Biological Early Relapse Predictors in Multiple Myeloma: An Analysis from the MMRF CoMMpass Study.

Prognostic Implication of Somatic Mutations by Next Generation Sequencing: an Analysis from the MMRF CoMMpass Study in Newly Diagnosed Multiple Myeloma Patients.

Indoleamine 2,3-dioxygenase 1 (IDO1) activity correlates with immune system abnormalities in multiple myeloma.

Indoleamine 2,3-dioxygenase 1 (IDO1) activity correlates with immune system abnormalities in multiple myeloma.

Minimal residual disease by flow cytometry and allelic-specific oligonucleotide real-time quantitative polymerase chain reaction in patients with myeloma receiving lenalidomide maintenance: A pooled analysis.